You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to www.journalgazette.net/newsletter and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.

Business

  • Column: OPEC swamps crude-oil prices
    Crude-oil prices collapsed to a four-year low on Thanksgiving Day, dropping as low as $67.75 per barrel after the Organization of the Petroleum Exporting Countries decided to leave production targets unchanged at its most recent meeting.
  • Who's in charge of Black Friday?
    What about those store managers in charge of making sure merchandise is on the shelves? The Journal Gazette spent some time with a Meijer store director on Friday to get a glimpse into his Black Friday.
  • Oil plunge a panacea for crude-reliant Asia
    A renewed plunge in oil prices is a worrying sign of weakness in the global economy that could shake governments dependent on oil revenues. It is also a panacea as pump prices fall, giving individuals more disposable income and lowering costs for
Advertisement
File/The Journal Gazette
Zimmer Holdings Inc. of Warsaw announced today it has agreed to acquire Biomet in a $13 billion deal.

Zimmer Holdings to acquire Biomet

Two of what have been called Warsaw's "big three" orthopedic companies announced today plans to become one in a more than $13 billion deal that would have Zimmer Holdings Inc. acquiring Biomet.

The boards of directors of the two companies have approved a definitive agreement for a cash and stock deal expected to be completed in the first quarter of 2015 valued at $13.35 billion, according to a news release this morning.

DePuy Synthes, part of Johnson & Johnson, is the other Warsaw-based company that has part of the "big three."

"The merger of Zimmer and Biomet will position the combined company as a leader in the $45 billion musculoskeletal industry and is aligned with Zimmer's strategic framework, which focuses on growth, operational excellence and prudent capital allocation," the news release said. "The combined company is expected to deliver attractive growth by offering a more comprehensive and scalable portfolio of solutions with enhanced cross-selling opportunities."

As a combined company, Zimmer and Biomet expect to be able to accelerate innovation and have a more diversified and predictable revenue mix consistent with a broader portfolio, the news release said.

"This combination is about achieving growth and cultivating best-in-class solutions," David Dvorak, Zimmer President and CEO, said in a statement. "We have a great deal of respect for what the management team and employees have accomplished at Biomet, and we are confident in their ability to be a very important part of the combined organization as we bring our two world-class companies together and cement Warsaw, Indiana as the musculoskeletal innovation capital of the world."

For more on this story, go to www.journalgazette.net after 3 a.m. Friday.

Advertisement